Details

Autor(en) / Beteiligte

• Farkouh, Michael E
• Domanski, Michael
• Sleeper, Lynn A
• Siami, Flora S
• Dangas, George
• Mack, Michael
• Yang, May
• Cohen, David J
• Rosenberg, Yves
• Solomon, Scott D
• Desai, Akshay S
• Gersh, Bernard J
• Magnuson, Elizabeth A
• Lansky, Alexandra
• Boineau, Robin
• Weinberger, Jesse
• Ramanathan, Krishnan
• Sousa, J. Eduardo
• Rankin, Jamie
• Bhargava, Balram
• Buse, John
• Hueb, Whady
• Smith, Craig R
• Muratov, Victoria
• Bansilal, Sameer
• King, Spencer
• Bertrand, Michel
• Fuster, Valentin

Titel

Strategies for Multivessel Revascularization in Patients with Diabetes

Ist Teil von

• The New England journal of medicine, 2012-12, Vol.367 (25), p.2375-2384

Ort / Verlag

Waltham, MA: Massachusetts Medical Society

Erscheinungsjahr

2012

Quelle

Electronic Journals Library

Beschreibungen/Notizen

• In this trial, patients with diabetes and multivessel coronary disease had a lower risk of MI and death if they were treated with CABG, as compared with coronary stenting with drug-eluting stents. However, the CABG group had an increased risk of stroke. Revascularization for patients with multivessel coronary artery disease is performed commonly throughout the world. In the United States alone, approximately 700,000 patients undergo multivessel coronary revascularization yearly. Of these patients, 25% have diabetes. 1 , 2 In the Bypass Angioplasty Revascularization Investigation (BARI) trial, patients with diabetes and multivessel disease who underwent coronary-artery bypass grafting (CABG) lived longer than did patients undergoing balloon angioplasty, a finding that led to guideline recommendations for CABG as the preferred approach for revascularization in such patients. 3 , 4 Outcomes from CABG improved with the advent of antithrombotic therapy and the use of arterial conduits. 5 , 6 In subsequent . . .